US: Dow-DuPont merger subject of September hearing by Senate Judiciary Committee
The merger between The Dow Chemical and DuPont is the topic of a hearing in September requested by one concerned US senator.
US Sen. Chuck Grassley, R-Iowa, serves as the chairman of the Senate’s Judiciary Committee and recently called for a hearing on the merger, and its effect on the seed and chemical industry. Details were not finalized for the hearing, set for late September, and it is unclear who will represent the two chemical companies at the hearing.
According to a statement on Grassley’s website, the hearing will “focus on the transactions currently being reviewed by antitrust regulators, and the current trend in consolidation of the seed and chemical industries.”
“The seed and chemical industries are critical to agriculture and the nation’s economy, and Iowans are concerned that this sudden consolidation in the industry could cause rising input costs in an already declining agriculture economy,” Grassley said in a statement.
The $130 billion “merger of equals,” as it has been dubbed, would result in a combined company to be known as DowDuPont. It would then spin off into three independent, publicly traded companies within 18 to 24 months after the merger is closed, and is subject to regulatory and board approval.
In addition to the Senate Judiciary Committee, the merger is being scrutinized by the Department of Justice and the European Union.
Full Content: Midland Daily News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Walmex Awaits Antitrust Ruling as Mexican Regulator Probes Alleged Practices
Oct 8, 2024 by
CPI
Crypto.com Sues SEC, Alleging Regulatory Overreach in Crypto Industry
Oct 8, 2024 by
CPI
Elite US Universities Face New Antitrust Suit Over Financial Aid Practices
Oct 8, 2024 by
CPI
Kirkland & Ellis Strengthens Antitrust Practice with New Partner from FTC
Oct 8, 2024 by
CPI
TikTok Hit with Lawsuits from 13 US States and DC
Oct 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh